These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34002893)

  • 1. α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
    Stuendl A; Kraus T; Chatterjee M; Zapke B; Sadowski B; Moebius W; Hobert MA; Deuschle C; Brockmann K; Maetzler W; Mollenhauer B; Schneider A
    Mov Disord; 2021 Nov; 36(11):2508-2518. PubMed ID: 34002893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology.
    Ishiguro Y; Tsunemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N
    Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.
    Yan S; Jiang C; Janzen A; Barber TR; Seger A; Sommerauer M; Davis JJ; Marek K; Hu MT; Oertel WH; Tofaris GK
    JAMA Neurol; 2024 Jan; 81(1):59-68. PubMed ID: 38048087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
    Taha HB; Ati SS
    CNS Neurosci Ther; 2023 Dec; 29(12):3741-3755. PubMed ID: 37416941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.
    Jiang C; Hopfner F; Berg D; Hu MT; Pilotto A; Borroni B; Davis JJ; Tofaris GK
    Mov Disord; 2021 Nov; 36(11):2663-2669. PubMed ID: 33826157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.
    Lucien F; Benarroch EE; Mullan A; Ali F; Boeve BF; Mielke MM; Petersen RC; Kim Y; Stang C; Camerucci E; Ross OA; Wszolek ZK; Knopman D; Bower J; Singer W; Savica R
    PLoS One; 2022; 17(4):e0264446. PubMed ID: 35395000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
    van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
    Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
    Lööv C; Scherzer CR; Hyman BT; Breakefield XO; Ingelsson M
    Cell Mol Neurobiol; 2016 Apr; 36(3):437-48. PubMed ID: 26993503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
    Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis.
    Xylaki M; Chopra A; Weber S; Bartl M; Outeiro TF; Mollenhauer B
    Mov Disord; 2023 Sep; 38(9):1585-1597. PubMed ID: 37449706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers.
    Zhao Y; Yang G
    Neurochem Int; 2021 Mar; 144():104974. PubMed ID: 33485881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.